Article Information
History
- October 7, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Beatriz Sánchez-Sendra1,
- Eliseo Albert2,
- Joao Zulaica1,
- Ignacio Torres2,
- Estela Giménez2,
- Pilar Botija3,
- María José Beltrán4,
- Celia Rodado5,
- Ron Geller1,† and
- David Navarro2,6,†,*
- 1Institute for Integrative Systems Biology (I2SysBio), Universitat de Valencia-CSIC, 46980, Valencia, Spain
- 2Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
- 3Dirección de Atención Primaria, Departamento de Salud Clínico-Malvarrosa, Hospital Clínico Universitario de Valencia, Valencia, Spain
- 4Dirección de Enfermería, Departamento de Salud Clínico-Malvarrosa, Hospital Clínico Universitario de Valencia, Valencia, Spain
- 5Comisión Departamental de control de Residencias. Departamento de Salud València Clínico Malvarrosa
- 6Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain
- ↵*Correspondence:
David Navarro, Microbiology Service, Hospital Clínico Universitario, Instituto de Investigación INCLIVA, Valencia, and Department of Microbiology, University of Valencia, Valencia, Spain. Av. Blasco Ibáñez 17, 46010 Valencia, Spain. Phone: 34(96)1973500; Fax: 34(96)3864173; E-mail: david.navarro{at}uv.es.
↵† Both senior authors contributed equally to the current work.
Posted October 07, 2021.
Neutralizing antibodies against SARS-CoV-2 variants of concern elicited by the Comirnaty® COVID-19 vaccine in nursing home residents
